Chugai Pharm ADR (CHGCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 09-2025 | 06-2025 | 03-2025 | 09-2024 | |
| Sales | 2,059,181 | 0 | 0 | 1,903,829 | 0 |
| Cost of Goods | 593,856 | N/A | N/A | 579,632 | N/A |
| Gross Profit | 1,465,325 | N/A | N/A | 1,324,198 | N/A |
| Operating Expenses | 450,085 | 0 | 0 | 422,939 | 0 |
| Operating Income | 1,016,096 | N/A | N/A | 901,897 | N/A |
| Interest Expense | -269 | 0 | 0 | -20 | 0 |
| Other Income | 8,896 | 0 | 0 | -5,445 | 0 |
| Pre-tax Income | 1,025,261 | 0 | 0 | 896,471 | 0 |
| Income Tax | 286,586 | N/A | N/A | 254,727 | N/A |
| Net Income Continuous | 738,675 | N/A | N/A | 641,744 | N/A |
| Net Income | $738,675 | $N/A | $N/A | $641,744 | $N/A |
| EPS Basic Total Ops | 0.22 | N/A | N/A | 0.20 | N/A |
| EPS Basic Continuous Ops | 0.22 | N/A | N/A | 0.20 | N/A |
| EPS Diluted Total Ops | 0.22 | N/A | N/A | 0.20 | N/A |
| EPS Diluted Continuous Ops | 0.22 | N/A | N/A | 0.20 | N/A |
| EPS Diluted Before Non-Recurring Items | 0.22 | 0.23 | 0.20 | 0.19 | 0.22 |
| EBITDA(a) | $1,016,096 | $N/A | $N/A | $901,890 | $N/A |